JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $6.86M | ﹤0.01% |
146,798
-32,978
| -18% | -$1.53M |
|
2302
PTC
PTC
$16.7B
| $6.85M | ﹤0.01% |
78,108
+1,119
| +1% | +$100K |
|
2303
CALL
Apollo Global Management
APO
$84.8B
| $6.85M | ﹤0.01% |
200,000
+100,000
| +100% | +$3.18M |
|
2304
Wipro
WIT
$19.4B
| $6.84M | ﹤0.01% |
3,160,396
+1,024,296
| +48% | +$2.26M |
|
|
HSII
2305
DELISTED
Heidrick & Struggles
HSII
| $6.83M | ﹤0.01% |
233,624
+17,907
| +8% | +$628K |
|
2306
CALL
Kimberly-Clark
KMB
$36.8B
| $6.83M | ﹤0.01% |
+51,000
| New | +$6.58M |
|
|
CERN
2307
CALL
DELISTED
Cerner Corp
CERN
| $6.82M | ﹤0.01% |
95,000
-5,000
| -5% | -$337K |
|
|
CERN
2308
PUT
DELISTED
Cerner Corp
CERN
| $6.82M | ﹤0.01% |
95,000
-9,800
| -9% | -$661K |
|
2309
PUT
Ecolab
ECL
$77.4B
| $6.8M | ﹤0.01% |
35,400
| – | – |
|
|
X
2310
CALL
DELISTED
US Steel
X
| $6.8M | ﹤0.01% |
450,000
+250,000
| +125% | +$3.85M |
|
2311
Chewy
CHWY
$9.2B
| $6.8M | ﹤0.01% |
+204,025
| New | +$6.89M |
|
|
CMBM
2312
DELISTED
Cambium Networks
CMBM
| $6.8M | ﹤0.01% |
+715,400
| New | +$6.87M |
|
|
IMMU
2313
DELISTED
Immunomedics Inc
IMMU
| $6.79M | ﹤0.01% |
490,343
+66,135
| +16% | +$995K |
|
2314
Cato Corp
CATO
$66.7M
| $6.78M | ﹤0.01% |
560,489
+123,868
| +28% | +$1.69M |
|
2315
PUT
AvalonBay Communities
AVB
$26.3B
| $6.75M | ﹤0.01% |
33,500
-3,700
| -10% | -$750K |
|
2316
Alliant Energy
LNT
$18.2B
| $6.74M | ﹤0.01% |
137,692
+11,559
| +9% | +$551K |
|
2317
Box
BOX
$4.66B
| $6.73M | ﹤0.01% |
383,585
+222,840
| +139% | +$4.26M |
|
2318
Grupo Cibest SA
CIB
$22.7B
| $6.73M | ﹤0.01% |
132,272
-30,123
| -19% | -$1.5M |
|
|
BLCM
2319
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $6.73M | ﹤0.01% |
338,115
-80,887
| -19% | -$2.19M |
|
2320
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $6.72M | ﹤0.01% |
64,333
+6,226
| +11% | +$650K |
|
2321
TransUnion
TRU
$15.5B
| $6.72M | ﹤0.01% |
93,177
-25,292
| -21% | -$1.73M |
|
2322
Black Stone Minerals
BSM
$3.06B
| $6.71M | ﹤0.01% |
439,135
+378,824
| +628% | +$6.46M |
|
2323
Hilltop Holdings
HTH
$2.28B
| $6.7M | ﹤0.01% |
322,219
-8,989
| -3% | -$181K |
|
2324
Protagonist Therapeutics
PTGX
$9.8B
| $6.69M | ﹤0.01% |
558,729
+278,066
| +99% | +$3.07M |
|
2325
CALL
Regeneron Pharmaceuticals
REGN
$83B
| $6.68M | ﹤0.01% |
21,500
+8,200
| +62% | +$2.73M |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.